NCT07005947Completed
Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project
Source: ClinicalTrials.gov · Last updated 2 Jul 2026
Brief summary (registry, in English)
This is a prospective, longitudinal study involving 300 participants for a single visit to compare Long COVID-19 neurocutaneous biosignatures with those of other disorders affecting the sensory and autonomic nervous system.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 237 (actual)
- First submitted
- 3 Jun 2025
- Start date
- 30 Nov 2023
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- CND Life Sciences
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT07005947
What you commit to
- Study type: Observational
- Participants enrolled: 237
- From 30 Nov 2023 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinical evidence of severe peripheral vascular disease
- History of ulceration, poor wound healing or vascular claudication
- History of allergic reaction to local anesthesia (for biopsy collection)
- History of a bleeding disorder
Other
- Use of oral anticoagulants (aspirin or Plavix alone is allowed)
Who the study is looking for
- Long COVID-19 defined by NIH PASC criteria OR
- Acute COVID-19 who tested positive for COVID-19 without persistent symptoms OR
- Postural orthostatic tachycardia syndrome (POTS) OR
- Diabetic neuropathy
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CND Life Sciences Coordinator of this site? Confirm its status | Scottsdale | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.